ONCASPAR is a Intramuscular; Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Baxalta Us Inc.. The primary component is Pegaspargase.
Product ID | 0944-3810_5b739c5e-49a1-48f5-9788-b407217a9a97 |
NDC | 0944-3810 |
Product Type | Human Prescription Drug |
Proprietary Name | ONCASPAR |
Generic Name | Pegaspargase |
Dosage Form | Injection, Solution |
Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
Marketing Start Date | 1994-02-01 |
Marketing Category | BLA / BLA |
Application Number | BLA103411 |
Labeler Name | Baxalta US Inc. |
Substance Name | PEGASPARGASE |
Active Ingredient Strength | 750 [iU]/mL |
Pharm Classes | Asparaginase [CS],Asparagine-specific Enzyme [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 1994-02-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA103411 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1994-02-01 |
Marketing End Date | 2020-05-16 |
Ingredient | Strength |
---|---|
PEGASPARGASE | 750 [iU]/mL |
SPL SET ID: | 7fc3d37f-df69-484f-9ab1-7ba1c4947898 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0944-3810 | ONCASPAR | Pegaspargase |
72694-954 | ONCASPAR | Pegaspargase |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ONCASPAR 79384548 not registered Live/Pending |
SERVIER IP UK LIMITED 2023-10-16 |
ONCASPAR 74278090 1809883 Live/Registered |
SERVIER IP UK LIMITED 1992-05-26 |